Ερευνητικό υλικό ΕΚΠΑ

Response to correspondence: Testing for myelin oligodendrocyte glycoprotein antibody (MOG-IgG) in typical MS

Αγγλικά

Δεν υπάρχει περίληψη

2019

Breza, M.
Koutsis, G.
Tzartos, J.S.
Velonakis, G.
Evangelopoulos, M.E.
Tzanetakos, D.
Karagiorgou, K.
Angelopoulou, G.
Kasselimis, D.
Potagas, C.
Anagnostouli, M.
Stefanis, L.
Kilidireas, C.

Multiple Sclerosis and Related Disorders

Elsevier B.V.

35

156-157

biological marker; complement; immunoglobulin G; immunoglobulin G1 antibody; myelin oligodendrocyte glycoprotein antibody; protein antibody; unclassified drug; immunoglobulin G; myelin oligodendrocyte glycoprotein, antibody titer; antigen specificity; brain damage; cell assay; clinical feature; conus medullaris; corpus callosum; demyelinating disease; disease association; false positive result; human; immunoassay; Letter; multiple sclerosis; nuclear magnetic resonance imaging; patient care; phenotype; prognosis; demyelinating disease, Demyelinating Diseases; Humans; Immunoglobulin G; Multiple Sclerosis; Myelin-Oligodendrocyte Glycoprotein

https://doi.org/10.1016/j.msard.2019.07.018

10.1016/j.msard.2019.07.018

https://pergamos.lib.uoa.gr/uoa/dl/object/2997727